HOSPITAL Umum Sarawak (SGH) in Kuching has been selected by Roche Pharma-ceuticals as its site for a first-in-human (FIH) clinical trial.
Roche is the first top multinational company to bring its FIH trials under a rheumatology indication to Malaysia, a testament to the country’s growing clinical trial capabilities.
